Laxmi Organic Industries Ltd. · NSE:LXCHEM
Laxmi Organic Industries — Q4 FY25 Earnings Presentation
33 slides from Laxmi Organic Industries's earnings presentation, May 21, 2025
Slide 1: Corrigendum to Investor Presentation cover letter
May 21, 2025 BSE Limited National Stock Exchange Limited Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, 1st Floor, New Trading Ring, Bandra (E), Rotunda Building, P. J. Towers, Mumbai – 400 051 Dalal Street, Fort, Trading Symbol: LXCHEM Mumbai – 400 001 Scrip Code: 543277 D
Slide 2: Geared to Win; Geared for Growth
Geared to Win; Geared for Growth Investor Presentation – Q4 FY25 May 2025 www.laxmi.com
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), have been prepared by Laxmi Organic Industries Limited (the “Company”) solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities and shall no
Slide 4: Company Overview
Company Overview www.laxmi.com
Slide 5: Laxmi Organic Industries Ltd. – A Leading Indian Chemical Company
Laxmi Organic Industries Ltd. – A Leading Indian Chemical Company Essentials BU - Lean & Reliable Specialties BU - World Class Technology Supplier serving diverse industries platforms with strong development capabilities serving diverse industries Emphasis on Development, Quality, and ESG. Large, gl
Slide 6: Diversified Business Catering to Varied Industries
Diversified Business Catering to Varied Industries Essentials Specialties Pharmaceuticals Agrochemicals Inks & Paints Coatings Pharmaceuticals Agrochemicals Dyes & Pigments Personal Care End User Industries Printings Packaging Adhesives Fragrance & Flavour Paints & Coating Flame Redundant Electronic
Slide 7: Leadership Ambitions
Geared to Win Demonstrated 1 Cost and Technology leadership capability of Leadership absorbing and Market leadership – top 3 in scaling best in 2 Essentials (ex-China) and top class 5 in Specialties globally technologies Unlevered Balance Sheet – 3 Partner of choice for customers ready to invest Lar
Slide 8: Track Record of technology absorption and in-house R&D capabilities
Track Record of technology absorption and in-house R&D capabilities Acquisition of Ketene/Diketene Addition of >40 New Derivatives for multiple industries business 2010 including agro and pharma and CASE to the Acquired know-how of some Specialties Platform acquired from Clariant derivatives f
Slide 9: Strategically located Manufacturing Sites
Strategically located Manufacturing Sites Europe Mahad (2 Sites) As part of the global footprint, we have offices in Amsterdam (Netherlands) and Shanghai (China). Tank • Land parcel: 45 acres operations in Belgium and Italy. • Land Occupancy: 90% China • Product Mix: o Essentials – 60% o Specialties
Slide 10: Network and Alliances
Network and Alliances Ravi Goenka Dr Rajan Venkatesh Harshvardhan Goenka Rajeev Goenka Manish Chokhani Executive Chairman Managing Director & Chief Executive Director – Strategy Non-Executive Director Non-Executive Director Executive Officer & Business Development Bachelor’s degree in Chemical Maste
Slide 11: Strong Management Team
Strong Management Team Harshvardhan Goenka (ED – Strategy & BD) Dr. Milind Vaidya (Executive VP R&D and Specialties Marketing) B.Sc. from Babson College, School of Business in Boston, USA, and 11 years of experience in the chemicals industry. Doctorate in Science from ICT. 25+ years of experience in
Slide 12: Our Core Values and Integrated EHS Program
Our Core Values and Integrated EHS Program Lost Time Injury (LTI) and Process Safety incident (PSI) targets for VPs and above Employee Health & Safety INTEGRITY INNOVATION Accident and EHS Risk To do what is right in the To create a culture where Incident Analysis Assessment interest of all our stak
Slide 13: Accreditation & Certification
Accreditation & Certification Recognized for its sustainable practices Accredited facilities Biobased Product Label for Ethyl Acetate Going beyond the regulatory compliances Disclosure of Business Responsibility & Sustainability Report (BRSR) LAXMI ORGANIC INDUSTRIES LIMITED | Q4FY25 12
Slide 14: Awards & Accolades
Awards & Accolades State Level Award - DISH Certificate of Appreciation from National Safety Council of India for consecutive 4 years Fire drill awards from MIDC Certificate of Appreciation from National Safety Council of India for consecutive 4 years • Received National Level Appreciation Certifica
Slide 15: Geared for Growth – Strategic Plan
Geared for Growth - Strategic Plan www.laxmi.com
Slide 16: Geared for Growth: Historical Performance
Geared for Growth: Historical Performance Growth Fueled by Strategic Acquisitions, Fast Technology Absorption together with achieving >20%+ Revenue Contribution from New Products launched in last 5 years Capacity Addition for ethyl acetate and acetaldehyde Acquired Ketene / Foray into Diketene bus
Slide 17: Geared for Growth: Positioned for the next Growth Phase
Geared for Growth: Positioned for the next Growth Phase Pivoted for the Next Growth Customer Needs Proven Success Phase Innovation 1 Product 1 Customer 2 2 Platform Plant Transited Price Product 3 Platform 3 Plant Strategic shift to Customer Centric Business Approach helped us gain more market and i
Slide 18: Geared for Growth: Financial Steering for FY28 Plan
Geared for Growth: Financial Steering for FY28 Plan Essentials Specialties Ketene/ Other / New Technology Platform Esterification Acetylation Fluorination Diketene Platforms Asset Turn Asset Turn 3x - 5x 1x - 2x Targeted Financial KPIs EBITDA Margin EBITDA Margin 8-12% 20-25% Combined ROCE of 20% LA
Slide 19: Consolidated Enterprise
Consolidated Enterprise (in INR Mn.) Capex Plan Revenue EBITDA* ROCE ~2x ~2.7x 7,500 20% 3,500 28,650 10% 2,839 FY 25 & 26 FY 26-28 FY 24 FY 28 E FY 24 FY 28 E FY24 FY28 E Key Highlights: Incremental Capex Investment Plan of ~ INR 11,000 Mn • On Consolidated basis the company plans to achieve RoCE:
Slide 20: Essentials: Strategy and Right to Win
Essentials: Strategy and Right to Win Go Deeper, Go Broader Strategy Grow in the Existing Products Enter in New Products • Retain India market share • Portfolio expansion • Grow exports • De-risking of business • Focus on continuous operational efficiencies • Future ready for biobased products Lean
Slide 21: Specialties: Strategy and Right to Win
Specialties : Strategy and Right to Win Specialties Growth Drivers Strategy Expand & Optimise in Incumbents Enter in New Products • Grow market share • Fluro assets to start delivering revenue in FY25 • Focus on global customers • To have min. 20% sales from new products • Improve cost leadership vi
Slide 22: Financial Highlights Q4 & FY25
Financial Highlights Q4 & FY25 www.laxmi.com
Slide 23: From the desk of MD & CEO
From the desk of MD & CEO FY25 Reflections We have achieved 11% volume growth and a 9.4% EBITDA growth YoY, while maintaining our profitability despite the prevailing environment and the evolving geopolitical backdrop and its consequences. This growth was driven by our focus on, a) operational effic
Slide 24: Capex Update – Dahej
Capex Update – Dahej Inorganic EC Received on 04-May-24 Bhoomi Pujan at Dahej Site on 10-May-24 Civil foundation completed. Organic CTE received on Other activities progressing 20-Jun-24 on schedule. Q1 Q2 Q3 Q1 FY25 FY25 FY25 FY26 EC and Factory License Public hearing received for Dahej site Comple
Slide 25: Capex Update – Lote
Capex Update – Lote COVID period Acquired Q3FY20 Q2 FY’21 Q3 FY’21 Q1 FY’22 Q3 FY’23 Acquisition of Land development Kilo Lab setup created at Civil & structural work Equipment's arrived from technology and assets work started at Lote Mahad - familiarization to completed Italy from Miteni, Italy Mit
Slide 26: Consolidated Financial Highlights – Q4 & FY25
Consolidated Financial Highlights – Q4 & FY25 (in INR Mn.) Revenue EBITDA PAT Key Highlights +5% +9% -6% • Total volumes grew by 1% in 28,550 29,854 2,796 1,205 Q4FY25 and 11% in FY25 on a y- 2,557 1,135 o-y basis. -51% • Consolidated Revenue for -9% -34% 443 Q4FY25 dropped by 9% and for 900 7,821 7
Slide 27: Consolidated Business Highlights – Q4 & FY25
Consolidated Business Highlights – Q4 & FY25 (in INR Mn.) Essentials Revenue Specialties Revenue +1% +14% 20,195 20,364 9,491 8,355 -10% -7% 5,457 4,898 2,363 2,199 Q4FY24 Q4FY25 FY24 FY25 Q4FY24 Q4FY25 FY24 FY25 Gross margin Contribution (in %) Gross margin Contribution (in %) 34% 33% 36% 37% Q4FY2
Slide 28: De-risking continues to Deliver
De-risking continues to Deliver* Exports Continue to remain Relevant Revenue from Top 10 Customers 41% 29% 30% 35% 36% 34% 27% 23% 71% 70% 65% 64% FY22 FY23 FY24 FY25 FY22 FY23 FY24 FY25 Exports Domestic *On consolidated basis LAXMI ORGANIC INDUSTRIES LIMITED | Q4FY25 27
Slide 29: Export Revenue Break-up / Industry Wise Revenue
De-risking continues to Deliver Q4FY24 Vs Q4FY25 FY24 Vs FY25 Export Revenue Break-up 6% 2% 5% 8% 28% 25% 26% 24% 31% 36% 17% 17% Q4FY24 Q4FY25 FY24 FY25 3% 17% 9% 15% 14% 7% 13% 32% 32% 7% 12% 15% America Europe Middle East Rest of Asia Pacific Africa China Q4FY24 Vs Q4FY25 FY24 Vs FY25 Industry Wi
Slide 30: Consolidated Profit & Loss – Q4 & FY25
Consolidated Profit & Loss – Q4 & FY25 (in INR Mn.) Particulars (Rs. Mn) Consolidated Q4FY25 Q4FY24 Y-o-Y FY25 FY24 Y-o-Y Revenue from operations 7,097 7,821 -9.3% 29,854 28,550 4.6% COGS 4,639 5,040 19,476 19,248 Gross Margin 2,458 2,781 -11.6% 10,378 9,303 11.6% Gross Margins (%) 34.6% 35.6% -93 b
Slide 31: Consolidated Balance Sheet
Consolidated Balance Sheet (in INR Mn.) Assets (in INR Mn.) Mar-25 Mar-24 Equity and Liabilities (in INR Mn.) Mar-25 Mar-24 ASSETS EQUITY AND LIABILITIES Non-current assets Equity Share Capital 554 552 Property, Plant and Equipment 11,617 8,708 Other Equity 18,513 17,425 Capital work-in-progress 3,9
Slide 32: Consolidated Abridged Cash Flow Statement
Consolidated Abridged Cash Flow Statement (in INR Mn.) Particulars (in INR Mn.) FY25 FY24 Profit before Tax 1,605 1,708 Adjustment for Non-Operating Items 1,386 1,192 Operating Profit before Working Capital Changes 2,992 2,900 Changes in Working Capital (1,657) 3,086 Cash Generated from Operations 1
Slide 33: Thank You
Thank You Company: Laxmi Organic Industries Limited Investor Relations: Strategic Growth Advisors Pvt. Ltd. www.laxmi.com www.sgapl.net CIN: L24200MH1989PLC051736 CIN: U74140MH2010PTC204285 Mr. Sagar Shroff / Mr. Tanay Shah Mr. Aniket Hirpara Email: sagar.shroff@sgapl.net / tanay.shah@sgapl.net Emai
Laxmi Organic Industries — Q4 FY25 Earnings Presentation on 6ix